Envafolimab Combined With GEMOX in First-line Treatment of Advanced GBC
NCT06013943
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Gallbladder Cancer
Interventions
DRUG:
Envafolimab+Gemox
Sponsor
Eastern Hepatobiliary Surgery Hospital